Halozyme Therapeutics (HALO) Financials: Revenue & Earnings

HALO price $129.16 +0.67 +0.52%

Ticker
HALO
Price
$129.16
Change
+0.67 +0.52%
Market cap ?
$14.66B
P/E ?
36.37
Forward P/E ?
14.99
Dividend yield ?
0.00%
Beta ?
0.88
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
58
Value
41
Quality
78
Growth
56

Stocklytics score rationale: value 41, quality 78, growth 56.

Financials

2016201720182019202020212022202320242025
14669100031661300015186200019599200026759400044331000066011600082925300010153240001396611000

Halozyme Therapeutics, Inc. is a biopharmaceutical company headquartered in San Diego, California, with operations spanning the United States, Switzerland, Ireland, Belgium, Japan, and other international markets. At its core is the proprietary ENHANZE drug delivery platform, which utilizes a patented recombinant human hyaluronidase enzyme (rHuPH20). This innovative technology significantly enhances the subcutaneous…

Fair value

HALO fair value $287.57. Price $129.16. Price is 55% below fair value.

Below fair value, around its usual discount.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 806.22M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.12% (beta 0.9). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 113.50M. Net debt 2.01B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare HALO

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—2.30—490.85M
2026-08-062.281.79481.00M402.28M
2026-05-111.601.55376.71M358.60M
2026-02-17-0.242.15451.77M435.71M
2025-11-031.721.63354.26M446.51M
2025-08-051.541.23325.72M330.78M
2025-05-061.110.95264.86M280.97M
2025-02-181.261.17298.01M285.74M
2024-10-311.270.98290.08M292.83M
2024-08-060.910.76231.35M208.94M
2024-05-070.790.70195.88M199.78M
2024-02-200.820.83230.04M231.14M
2023-11-060.750.71216.03M222.63M
2023-08-080.740.63221.04M199.95M
2023-05-090.470.48162.14M175.51M
2023-02-210.480.47181.50M192.05M
2022-11-080.740.51208.98M191.17M
2022-08-090.530.50152.37M138.63M
2022-05-100.470.49117.28M128.25M
2022-02-220.420.41102.00M101.54M
2021-11-020.550.42115.83M106.96M
2021-08-090.660.43136.46M104.04M
2021-05-100.200.3189.02M83.98M
2021-02-230.500.53121.70M120.16M
2020-11-020.250.1965.32M48.99M
2020-08-100.190.2555.22M72.66M
2020-05-11-0.04-0.0125.35M12.68M
2020-02-24-0.24-0.1853.66M33.54M
2019-11-12-0.17-0.1246.23M32.63M
2019-08-06-0.10-0.1739.15M54.81M
2019-05-070.010.0156.95M56.95M
2019-02-21-0.01-0.0160.23M180.70M
2018-11-06-0.19-0.2325.56M30.94M
2018-08-07-0.16-0.2235.20M48.40M
2018-05-10-0.19-0.2130.87M35.78M
2018-02-200.850.72189.56M160.60M
2017-11-070.02-0.1063.73M318.50M
2017-08-08-0.23-0.2533.75M35.27M
2017-05-09-0.26-0.2529.57M28.46M
2017-02-28-0.21-0.3039.00M52.00M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2027-02-23Caudill CortneyOther9.25K——
2026-10-08Torley HelenBuy20.00K$18.41368.20K
2026-10-08Torley HelenSell4.81K$108.18520.34K
2026-10-08Torley HelenSell3.09K$108.91336.53K
2026-10-08Torley HelenSell11.90K$110.001.31M
2026-10-08Torley HelenSell200$110.5122.10K
2026-10-08Torley HelenSell20.00K$18.41368.20K
2026-10-07Torley HelenSell8.60K$111.03954.87K
2026-10-07Torley HelenSell10.30K$111.841.15M
2026-10-07Torley HelenSell900$112.78101.50K
2026-10-07Torley HelenSell200$113.6922.74K
2026-10-07Torley HelenSell20.00K$18.41368.20K
2026-10-06Torley HelenSell2.30K$107.90248.17K
2026-10-06Torley HelenSell6.00K$109.33656.00K
2026-10-06Torley HelenSell9.92K$109.891.09M
2026-10-06Torley HelenSell1.78K$110.81197.25K
2026-10-06Torley HelenSell20.00K$18.41368.20K
2026-10-01Daly James MBuy1.77K$106.94189.82K
2026-10-01Daly James MBuy1.17K——
2026-10-01Posard Matthew L.Sell730$107.1778.23K
2026-10-01Posard Matthew L.Sell3.30K$108.45357.90K
2026-10-01Posard Matthew L.Sell1.10K$109.57120.53K
2026-10-01Posard Matthew L.Sell100$110.0411.00K
2026-09-28Daly James MOther0——
2026-09-16Posard Matthew L.Sell3.10K$106.13329.01K
2026-09-16Posard Matthew L.Sell3.00K$106.83320.48K
2026-09-16Posard Matthew L.Sell8.90K$108.04961.12K
2026-09-16Posard Matthew L.Sell4.00K$108.99435.96K
2026-09-11Torley HelenBuy20.00K$18.41368.20K
2026-09-11Torley HelenSell15.49K$107.151.66M
2026-09-11Torley HelenSell4.51K$107.55484.83K
2026-09-11Torley HelenSell20.00K$18.41368.20K
2026-09-10Torley HelenSell14.59K$107.011.56M
2026-09-10Torley HelenSell5.41K$107.58582.23K
2026-09-10Torley HelenSell20.00K$18.41368.20K
2026-09-09Torley HelenSell13.30K$107.221.43M
2026-09-09Torley HelenSell6.60K$107.82711.19K
2026-09-09Torley HelenSell100$108.6710.87K
2026-09-09Torley HelenSell20.00K$18.41368.20K
2026-09-01Appelhans DannielleBuy1.78K$107.72191.53K
2026-09-01Appelhans DannielleBuy1.16K——
2026-08-19Torley HelenBuy20.00K$18.41368.20K
2026-08-19Torley HelenSell7.20K$106.36765.78K
2026-08-19Torley HelenSell9.60K$107.221.03M
2026-08-19Torley HelenSell3.20K$107.77344.85K
2026-08-19Torley HelenSell20.00K$18.41368.20K
2026-08-18Torley HelenSell5.70K$103.08587.88K
2026-08-18Torley HelenSell4.90K$104.11509.83K
2026-08-18Torley HelenSell9.40K$104.87985.82K
2026-08-18Torley HelenSell20.00K$18.41368.20K
2026-08-17Torley HelenSell900$98.9689.06K
2026-08-17Torley HelenSell500$100.4650.23K
2026-08-17Torley HelenSell2.10K$101.77213.71K
2026-08-17Torley HelenSell9.00K$102.55922.98K
2026-08-17Torley HelenSell7.50K$103.48776.12K
2026-08-17Torley HelenSell20.00K$18.41368.20K
2026-08-14Appelhans DannielleOther0——
2026-08-10Connaughton BernadetteSell1.63K$102.80167.15K
2026-07-08Torley HelenBuy1.92K$12.0723.21K
2026-07-08Torley HelenSell888$79.2870.40K
2026-07-08Torley HelenSell1.03K$80.1982.99K
2026-07-08Torley HelenSell1.92K$12.0723.21K
2026-07-01RAMSAY DAVID ABuy39.82K$77.013.07M
2026-07-01RAMSAY DAVID ABuy16.23K——
2026-07-01Snellgrove DarrenBuy127.43K$77.019.81M
2026-07-01Snellgrove DarrenBuy41.55K——
2026-07-01Connaughton BernadetteSell1.00K$76.3976.39K
2026-07-01Connaughton BernadetteSell625$77.2148.26K
2026-06-30RAMSAY DAVID ABuy10.00K——
2026-06-30RAMSAY DAVID ASell5.41K$78.27423.28K
2026-06-30RAMSAY DAVID ASell10.00K——
2026-06-29Krishnan MaheshBuy7.30K$38.46280.91K
2026-06-29Krishnan MaheshSell7.30K$75.00547.80K
2026-06-29Krishnan MaheshSell7.30K$38.46280.91K
2026-06-12Snyder Mark HowardBuy5.03K——
2026-06-12Snyder Mark HowardSell2.71K$69.50188.69K
2026-06-12Snyder Mark HowardSell5.03K——
2026-06-08Snellgrove DarrenOther0——
2026-06-03Torley HelenBuy10.00K$12.07120.70K
2026-06-03Torley HelenSell400$66.3726.55K
2026-06-03Torley HelenSell1.50K$67.67101.51K
2026-06-03Torley HelenSell2.00K$68.74137.47K
2026-06-03Torley HelenSell6.10K$69.69425.12K
2026-06-03Torley HelenSell10.00K$12.07120.70K
2026-06-02Torley HelenBuy20.00K$12.07241.40K
2026-06-02Torley HelenSell16.60K$66.311.10M
2026-06-02Torley HelenSell3.40K$66.75226.93K
2026-06-02Torley HelenSell20.00K$12.07241.40K
2026-06-01Torley HelenSell1.61K$66.39106.88K
2026-06-01Torley HelenSell12.99K$67.41875.59K
2026-06-01Torley HelenSell5.40K$68.35369.14K
2026-06-01Torley HelenSell20.00K$12.07241.40K
2026-06-01Connaughton BernadetteSell1.62K$66.21107.59K
2026-05-13Torley HelenBuy10.00K$12.07120.70K
2026-05-13Torley HelenSell2.10K$68.10143.01K
2026-05-13Torley HelenSell3.35K$68.88230.75K
2026-05-13Torley HelenSell3.95K$69.79275.66K
2026-05-13Torley HelenSell600$70.8142.49K
2026-05-13Torley HelenSell10.00K$12.07120.70K
2026-05-12Torley HelenBuy20.00K$12.07241.40K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 690, holders +35 vs prior quarter. Ownership 105.46%.

HolderSharesChangeChange %Value
BLACKROCK, INC.13.27M6.04K+0.05%1.04B
VANGUARD CAPITAL MANAGEMENT LLC5.35M80.09K+1.52%418.85M
VANGUARD PORTFOLIO MANAGEMENT LLC5.30M49.80K+0.95%414.75M
STATE STREET CORP5.18M241.58K+4.89%405.38M
INVESCO LTD.3.18M-834.50K-20.80%248.74M
MORGAN STANLEY2.83M270.29K+10.55%221.71M
BOSTON PARTNERS2.77M89.89K+3.35%216.82M
BANK OF AMERICA CORP /DE/2.74M-172.55K-5.92%214.50M
GEODE CAPITAL MANAGEMENT, LLC2.52M14.16K+0.57%197.28M
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC2.51M-14.93K-0.59%196.54M
SNYDER CAPITAL MANAGEMENT L P2.40M73.02K+3.14%187.54M
DIMENSIONAL FUND ADVISORS LP2.09M9.74K+0.47%163.54M
D. E. SHAW & CO., INC.2.01M137.77K+7.37%157.05M
LOS ANGELES CAPITAL MANAGEMENT LLC1.94M1.25M+180.91%151.69M
ROYAL LONDON ASSET MANAGEMENT LTD1.81M200.26K+12.43%141.73M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP1.70M-213.53K-11.13%133.42M
TWO SIGMA INVESTMENTS, LP1.65M68.32K+4.31%129.40M
UBS GROUP AG1.49M578.22K+63.26%116.80M
FULLER & THALER ASSET MANAGEMENT, INC.1.49M25.72K+1.76%116.70M
NORGES BANK1.48M1.48MNew116.13M
FIRST TRUST ADVISORS LP1.42M-65.28K-4.40%110.91M
LSV ASSET MANAGEMENT1.41M38.70K+2.82%110.38M
ALLIANCEBERNSTEIN L.P.1.70M-39.96K-2.30%109.65M
STEPHENS INVESTMENT MANAGEMENT GROUP LLC1.39M174.15K+14.29%109.02M
WELLS FARGO & COMPANY/MN1.39M-145.31K-9.46%108.83M

Earnings and financials

Halozyme Therapeutics, Inc. (HALO) trades at $129.16, with a market cap of $14.66B and a trailing P/E of 36.37. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
14669100031661300015186200019599200026759400044331000066011600082925300010153240001396611000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Halozyme Therapeutics (HALO) Financials: Revenue & Earnings

HALO$129.16+0.67 +0.52%

$14.66B

Market Cap

36.37

P/E

14.99

Forward P/E

58

Score

Price History